Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Other Non-Current Liabilities (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Other Non-Current Liabilities for 4 consecutive years, with $2.1 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities rose 9.38% year-over-year to $2.1 billion, compared with a TTM value of $2.1 billion through Sep 2025, up 9.38%, and an annual FY2024 reading of $1.8 billion, down 4.32% over the prior year.
  • Other Non-Current Liabilities was $2.1 billion for Q3 2025 at GE HealthCare Technologies, up from $2.0 billion in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $2.1 billion in Q3 2025 and bottomed at $1.6 billion in Q4 2022.
  • Average Other Non-Current Liabilities over 4 years is $1.9 billion, with a median of $1.8 billion recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities rose 17.09% in 2023, then decreased 4.32% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $1.6 billion in 2022, then grew by 17.09% to $1.9 billion in 2023, then fell by 4.32% to $1.8 billion in 2024, then increased by 16.93% to $2.1 billion in 2025.
  • Business Quant data shows Other Non-Current Liabilities for GEHC at $2.1 billion in Q3 2025, $2.0 billion in Q2 2025, and $1.8 billion in Q1 2025.